Stem cell therapy for fanconi anemia

Qing-Shuo Zhang

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Citation (Scopus)

Abstract

Stem cell therapy is the administration of stem cells to a patient to treat or prevent a disease. Since stem cells possess the long-term self-renewal capacity and provide daughter cells that differentiate into the specialized cells of each tissue, stem cell therapy will theoretically improve the disease condition for the lifetime of the patient. As the most widely used stem cell therapy, bone marrow transplantation is the treatment of choice for many kinds of blood disorders, including anemias, leukemias, lymphomas, and rare immunodeficiency diseases. For the fatal genetic blood disorder Fanconi anemia, allogeneic bone marrow transplantation has remained the only curative treatment. But the recent advances in stem cell and gene therapy fields may provide promising opportunities for an alternative or even better management of Fanconi anemia. Many of these new ideas and opportunities are also useful for treating other blood diseases that affect hematopoietic stem cells, such as sickle cell anemia, severe combined immunodeficiencies, and beta-thalassemias. In this chapter, these advances along with their challenges and limitations will be thoroughly discussed.

Original languageEnglish (US)
Title of host publicationAdvances in Experimental Medicine and Biology
PublisherSpringer New York LLC
Pages19-28
Number of pages10
DOIs
StatePublished - Jan 1 2018

Publication series

NameAdvances in Experimental Medicine and Biology
Volume1083
ISSN (Print)0065-2598
ISSN (Electronic)2214-8019

Fingerprint

Fanconi Anemia
Cell- and Tissue-Based Therapy
Stem cells
Stem Cells
Blood
Bone Marrow Transplantation
Bone
Severe Combined Immunodeficiency
Inborn Genetic Diseases
Hematologic Diseases
beta-Thalassemia
Homologous Transplantation
Gene therapy
Sickle Cell Anemia
Rare Diseases
Hematopoietic Stem Cells
Genetic Therapy
Anemia
Lymphoma
Leukemia

Keywords

  • Fanconi anemia
  • Hematopoietic stem cell
  • Stem cell therapy

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Zhang, Q-S. (2018). Stem cell therapy for fanconi anemia. In Advances in Experimental Medicine and Biology (pp. 19-28). (Advances in Experimental Medicine and Biology; Vol. 1083). Springer New York LLC. https://doi.org/10.1007/5584_2017_67

Stem cell therapy for fanconi anemia. / Zhang, Qing-Shuo.

Advances in Experimental Medicine and Biology. Springer New York LLC, 2018. p. 19-28 (Advances in Experimental Medicine and Biology; Vol. 1083).

Research output: Chapter in Book/Report/Conference proceedingChapter

Zhang, Q-S 2018, Stem cell therapy for fanconi anemia. in Advances in Experimental Medicine and Biology. Advances in Experimental Medicine and Biology, vol. 1083, Springer New York LLC, pp. 19-28. https://doi.org/10.1007/5584_2017_67
Zhang Q-S. Stem cell therapy for fanconi anemia. In Advances in Experimental Medicine and Biology. Springer New York LLC. 2018. p. 19-28. (Advances in Experimental Medicine and Biology). https://doi.org/10.1007/5584_2017_67
Zhang, Qing-Shuo. / Stem cell therapy for fanconi anemia. Advances in Experimental Medicine and Biology. Springer New York LLC, 2018. pp. 19-28 (Advances in Experimental Medicine and Biology).
@inbook{2d0a7b5edf434a1ea964c0e43cd04632,
title = "Stem cell therapy for fanconi anemia",
abstract = "Stem cell therapy is the administration of stem cells to a patient to treat or prevent a disease. Since stem cells possess the long-term self-renewal capacity and provide daughter cells that differentiate into the specialized cells of each tissue, stem cell therapy will theoretically improve the disease condition for the lifetime of the patient. As the most widely used stem cell therapy, bone marrow transplantation is the treatment of choice for many kinds of blood disorders, including anemias, leukemias, lymphomas, and rare immunodeficiency diseases. For the fatal genetic blood disorder Fanconi anemia, allogeneic bone marrow transplantation has remained the only curative treatment. But the recent advances in stem cell and gene therapy fields may provide promising opportunities for an alternative or even better management of Fanconi anemia. Many of these new ideas and opportunities are also useful for treating other blood diseases that affect hematopoietic stem cells, such as sickle cell anemia, severe combined immunodeficiencies, and beta-thalassemias. In this chapter, these advances along with their challenges and limitations will be thoroughly discussed.",
keywords = "Fanconi anemia, Hematopoietic stem cell, Stem cell therapy",
author = "Qing-Shuo Zhang",
year = "2018",
month = "1",
day = "1",
doi = "10.1007/5584_2017_67",
language = "English (US)",
series = "Advances in Experimental Medicine and Biology",
publisher = "Springer New York LLC",
pages = "19--28",
booktitle = "Advances in Experimental Medicine and Biology",
address = "United States",

}

TY - CHAP

T1 - Stem cell therapy for fanconi anemia

AU - Zhang, Qing-Shuo

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Stem cell therapy is the administration of stem cells to a patient to treat or prevent a disease. Since stem cells possess the long-term self-renewal capacity and provide daughter cells that differentiate into the specialized cells of each tissue, stem cell therapy will theoretically improve the disease condition for the lifetime of the patient. As the most widely used stem cell therapy, bone marrow transplantation is the treatment of choice for many kinds of blood disorders, including anemias, leukemias, lymphomas, and rare immunodeficiency diseases. For the fatal genetic blood disorder Fanconi anemia, allogeneic bone marrow transplantation has remained the only curative treatment. But the recent advances in stem cell and gene therapy fields may provide promising opportunities for an alternative or even better management of Fanconi anemia. Many of these new ideas and opportunities are also useful for treating other blood diseases that affect hematopoietic stem cells, such as sickle cell anemia, severe combined immunodeficiencies, and beta-thalassemias. In this chapter, these advances along with their challenges and limitations will be thoroughly discussed.

AB - Stem cell therapy is the administration of stem cells to a patient to treat or prevent a disease. Since stem cells possess the long-term self-renewal capacity and provide daughter cells that differentiate into the specialized cells of each tissue, stem cell therapy will theoretically improve the disease condition for the lifetime of the patient. As the most widely used stem cell therapy, bone marrow transplantation is the treatment of choice for many kinds of blood disorders, including anemias, leukemias, lymphomas, and rare immunodeficiency diseases. For the fatal genetic blood disorder Fanconi anemia, allogeneic bone marrow transplantation has remained the only curative treatment. But the recent advances in stem cell and gene therapy fields may provide promising opportunities for an alternative or even better management of Fanconi anemia. Many of these new ideas and opportunities are also useful for treating other blood diseases that affect hematopoietic stem cells, such as sickle cell anemia, severe combined immunodeficiencies, and beta-thalassemias. In this chapter, these advances along with their challenges and limitations will be thoroughly discussed.

KW - Fanconi anemia

KW - Hematopoietic stem cell

KW - Stem cell therapy

UR - http://www.scopus.com/inward/record.url?scp=85042932542&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85042932542&partnerID=8YFLogxK

U2 - 10.1007/5584_2017_67

DO - 10.1007/5584_2017_67

M3 - Chapter

C2 - 28687959

AN - SCOPUS:85042932542

T3 - Advances in Experimental Medicine and Biology

SP - 19

EP - 28

BT - Advances in Experimental Medicine and Biology

PB - Springer New York LLC

ER -